{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:38:15Z","timestamp":1793813895903,"version":"4.6.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.vaccine.2024.05.006","type":"journal-article","created":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T06:25:09Z","timestamp":1715408709000},"page":"3968-3973","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effectiveness of the varicella vaccine in the real world, a matched case-control study"],"prefix":"10.1016","volume":"42","author":[{"given":"Fang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.05.006_b0005","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0891-5520(05)70313-5","article-title":"The epidemiology of varicella-zoster virus infections","volume":"10","author":"Wharton","year":"1996","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.vaccine.2024.05.006_b0010","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1086\/315714","article-title":"Varicella mortality: trends before vaccine licensure in the United States, 1970\u20131994","volume":"182","author":"Meyer","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.006_b0015","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1080\/21645515.2018.1546525","article-title":"Global impact of varicella vaccination programs","volume":"15","author":"Varela","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2024.05.006_b0020","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1056\/NEJM200103293441302","article-title":"The effectiveness of the varicella vaccine in clinical practice","volume":"344","author":"V\u00e1zquez","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.05.006_b0025","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMoa064040","article-title":"Loss of vaccine-induced immunity to varicella over time","volume":"356","author":"Chaves","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.05.006_b0030","unstructured":"Beijing Varicella Management Technical Standard. In: Pang X, Lu L, editors. Technical standards on immunization program in Beijing. Science Press; 2019. p. 176\u201397 [in Chinese]."},{"key":"10.1016\/j.vaccine.2024.05.006_b0035","unstructured":"Beijing Center for Disease Control and Prevention. The technical guideline of varicella vaccine uses in Beijing. Chin J Prevent Med 2013;47:67\u20139 [in Chinese]."},{"key":"10.1016\/j.vaccine.2024.05.006_b0040","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.291.7.851","article-title":"Effectiveness over time of varicella vaccine","volume":"291","author":"V\u00e1zquez","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2024.05.006_b0045","first-page":"1055","article-title":"Field evaluation of vaccine efficacy","volume":"63","author":"Orenstein","year":"1985","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2024.05.006_b0050","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.jclinepi.2007.02.009","article-title":"Methodological issues in design and analysis of a matched case-control study of a vaccine's effectiveness","volume":"60","author":"Niccolai","year":"2007","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.vaccine.2024.05.006_b0055","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2105\/AJPH.79.3.340","article-title":"Modeling and variable selection in epidemiologic analysis","volume":"79","author":"Greenland","year":"1989","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2024.05.006_b0060","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/oxfordjournals.aje.a116813","article-title":"Simulation study of confounder-selection strategies","volume":"138","author":"Maldonado","year":"1993","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2024.05.006_b0065","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3741","article-title":"Global varicella vaccine effectiveness: a meta-analysis","volume":"137","author":"Marin","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2024.05.006_b0070","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajic.2017.07.029","article-title":"Incidence rate of breakthrough varicella observed in healthy children after 1 or 2 doses of varicella vaccine: results from a meta-analysis","volume":"46","author":"Zhu","year":"2018","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.vaccine.2024.05.006_b0075","article-title":"Clinical efficacy and effectiveness of alternative varicella vaccination strategies: an overview of reviews","volume":"33","author":"Ahern","year":"2023","journal-title":"Rev Med Virol"},{"issue":"22","key":"10.1016\/j.vaccine.2024.05.006_b0080","article-title":"Assessing varicella vaccine effectiveness and its influencing factors using health insurance claims data, Germany, 2006 to 2015","volume":"2017","author":"Rieck","year":"2017","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2024.05.006_b0085","doi-asserted-by":"crossref","first-page":"4936","DOI":"10.1016\/j.vaccine.2017.07.090","article-title":"Evaluating the effectiveness of the universal immunization program against varicella in Japanese children","volume":"35","author":"Hattori","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.05.006_b0090","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/j.vaccine.2021.03.085","article-title":"Ten-year follow-up on efficacy, immunogenicity and safety of two doses of a combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: results from five East European countries","volume":"39","author":"Prymula","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.05.006_b0095","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jinf.2021.07.035","article-title":"Epidemiological characteristics of varicella before and after the implementation of two-dose vaccination schedule in Chaoyang District, Beijing, 2007\u20132019","volume":"83","author":"Wang","year":"2021","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2024.05.006_b0100","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1542\/peds.112.2.e98","article-title":"A retrospective cohort study of the association of varicella vaccine failure with asthma, steroid use, age at vaccination, and measles-mumps-rubella vaccination","volume":"112","author":"Verstraeten","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2024.05.006_b0105","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1542\/peds.2004-1826","article-title":"Vaccine effectiveness during a varicella outbreak among schoolchildren: Utah, 2002\u20132003","volume":"115","author":"Haddad","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2024.05.006_b0110","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa021662","article-title":"Outbreak of varicella at a day-care center despite vaccination","volume":"347","author":"Galil","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.05.006_b0115","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1016\/j.vaccine.2013.06.075","article-title":"Single-dose varicella vaccine effectiveness in school settings in China","volume":"31","author":"Wang","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.05.006_b0120","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1097\/INF.0000000000000444","article-title":"Two-dose varicella vaccine effectiveness and rash severity in outbreaks of varicella among public school students","volume":"33","author":"Thomas","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2024.05.006_b0125","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.4161\/hv.23451","article-title":"Effectiveness of one and two doses of varicella vaccine in preventing laboratory-confirmed cases in children in Navarre","volume":"9","author":"Cenoz","year":"2013","journal-title":"Spain Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2024.05.006_b0130","doi-asserted-by":"crossref","first-page":"S425","DOI":"10.1093\/infdis\/jiac299","article-title":"The effectiveness of varicella vaccine: 25 years of postlicensure experience in the United States","volume":"226","author":"Shapiro","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.006_b0135","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1097\/INF.0b013e31828b7def","article-title":"Primary versus secondary failure after varicella vaccination: implications for interval between 2 doses","volume":"32","author":"Bonanni","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2024.05.006_b0140","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.1039537","article-title":"Long-term vaccine efficacy of a 2-dose varicella vaccine in China from 2011 to 2021: a retrospective observational study","volume":"10","author":"Shu","year":"2022","journal-title":"Front Public Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24005528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24005528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T10:22:34Z","timestamp":1728642154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24005528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":28,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0264410X24005528"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.05.006","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of the varicella vaccine in the real world, a matched case-control study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}